– ABOUT

OMIX3 and PX4 Platform

The OMIX3 platform represents a transformative step forward in Australia’s research infrastructure, delivering high-capacity, multi-omics capabilities to advance clinical research and precision medicine. With $15.83M in funding from the Australian Government’s Medical Research Future Fund, OMIX3 is a world-leading facility designed for integrated proteomics, metabolomics, and lipidomics analysis. OMIX3 provides an end-to-end solution for studying biological samples, from sample collection and biobanking to comprehensive multi-omics processing and secure data analysis.

Px4 Health, a flagship OMIX3 project, is an intergenerational study integrating multi-omics, lifestyle, and environmental data to uncover biomarkers and factors influencing disease and healthy ageing. With the capacity to process up to 30,000 clinical samples annually, Px4 Health aims to accelerate biomarker discovery and drive personalised healthcare innovations, setting a new standard for population-level multi-omics research.

With its scalable design and focus on unmet clinical needs, OMIX3 will advance diagnostics and treatments for chronic, infectious, and rare diseases. By enabling large-scale studies like Px4 Health and research into rare diseases, dental conditions, and infectious disease biomarkers, OMIX3 empowers researchers to address critical health challenges. Bioplatforms Australia’s multi-omics expertise will drive collaboration and keep Australian researchers at the forefront of medical innovation.